Stimulation of CD40 in human bladder carcinoma cells inhibits anti‐FAS/APO‐1 (CD95)‐induced apoptosis

• Published in: International journal of cancer 1998-09, Vol.77 (6), p.849-853
• Main Authors: Jakobson, Eva, Jönsson, Gun, Björck, Pia, Paulie, Staffan
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; Biological and medical sciences; Carcinoma - genetics; Carcinoma - metabolism; CD40 Antigens - metabolism; DNA, Neoplasm - metabolism; fas Receptor - metabolism; Flow Cytometry; Humans; Medical sciences; Mice; Nephrology. Urinary tract diseases; Tumor Cells, Cultured - metabolism; Tumors of the urinary system; Urinary Bladder Neoplasms - genetics; Urinary Bladder Neoplasms - metabolism; Urinary tract. Prostate gland
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/(SICI)1097-0215(19980911)77:6<849::AID-IJC9>3.0.CO;2-U

CD40 and the CD95 (Fas/APO‐1 antigen) are both members of the tumor necrosis factor receptor family. Whereas CD40 mediates a strong growth stimulatory signal in B cells, engagement of the CD95 receptor leads to growth inhibition and induction of apoptosis. As it has been reported that CD40 activation may rescue B cells from undergoing apoptosis, we were interested to see whether it had a similar effect in other cells expressing the CD40 receptor. We used epithelial tumor cells from the urinary bladder, a cell type that frequently expresses CD40 but for which no clear function of the molecule has been assigned. We found that the ligation of CD95 with the antibody anti‐APO‐1 induced apoptosis in most of the cell lines tested. Stimulation of CD40 with antibodies or a soluble construct of the CD40 ligand was shown to protect cells from apoptosis, as demonstrated by their ability to suppress the growth inhibition exerted by the anti‐APO‐1 antibody. Our results show that CD40 stimulation make cells less vulnerable to apoptosis induced via CD95 and suggest that CD40 expression on epithelial tumors may be associated with cell survival. Int. J. Cancer 77:849–853, 1998.© 1998 Wiley‐Liss, Inc.